Axon retraction following guanethidine treatment: studies of sympathetic neurons in tissue culture

Prevention of exercise-induced cardiac hypertrophy in rats by chemical sympathectomy (guanethidine treatment)

The effect of 'chemical sympathectomy', produced by daily intraperitoneal injections of guanethidine sulphate for six weeks, was studied in sedentary rats and in rats chronically exercised by swimming. The guanethidine-treatment itself caused the following changes. There was a reduction in the rate of weight gain resulting in a 7% lower final body weight. Organ content of noradrenaline was decreased by 90% in spleen and submandibular glands and by 83% in the heart. Urinary excretion of noradrenaline was also decreased, but to a lesser degree, both during rest (45% lower) and after acute exercise (46% lower), while the urinary excretion of adrenaline was no different from that of controls. There was a compensatory adrenal hypertrophy in the guanethidine-treated rats, with a significant increase in adrenal catecholamine levels that was more pronounced for noradrenaline (+45%) than for adrenaline (+11%). Chronic physical exercise produced the expected degree of cardiac hypertrophy in untreated rats, but this adaptive cardiac hypertrophy was completely absent in the exercised guanethidine-treated rats. The results indicate, firstly that a good degree of chemical sympathectomy was obtained and that the persistence of a considerable urinary excretion of catecholamines in the guanethidine-treated rats was due to a compensatory increase in the secretory activity of the adrenal medulla. Secondly, it is suggested that the adaptive cardiac hypertrophy produced by chronic exercise is not caused by a direct effect of the increased work load on the cardiac muscle cell, but is instead mediated by release of a trophic factor from cardiac sympathetic nerves, probably noradrenaline itself but possibly a secretory protein.

Neuronal degeneration and lipopigment formation in rat sympathetic ganglion after treatment with high-dose guanethidine

Degenerative changes in the rat superior cervical ganglion (SCG) were studied 3 months after treatment with a high-dose of guanethidine using microspectrofluorometry and electron microscopy. The density of the SCG neurons was decreased by 30% and by 60% following 1 and 2 weeks treatment respectively with guanethidine. Intraneuronal lipopigments were increased after the treatment, whereas cytoplasmic catecholamines were decreased. Electron microscopy revealed swollen mitochondria and a novel type of lipo-pigment in surviving neurons. The number and structure of small intensely fluorescent (SIF) cells remained unchanged after the treatment. The results suggest that accelerated lipid peroxidation processes might be involved in guanethidine neurotoxicity and that intraneuronal concentrations of catecholamines may be related to this toxicity.

The effects of 12-O-tetradecanoylphorbol-13-acetate (TPA) on axonal elongation and fasciculation

Ultrastructural examination of neurons treated with the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) confirmed our previous finding that TPA promoted neurite differentiation. At the low concentration of 16 nM TPA, the outgrowth of long neurites was correlated with the increased appearance of membrane-filled varicosities and filopodial extensions along the axons. In contrast, treatment with high concentrations of TPA (160 nM) produced dense outgrowths which were shorter in length and organized as thick fascicles. Increased neurite fasciculation appeared to result from the enhanced side-to-side interactions of neighboring neurites by a neural cell adhesion molecule. Axons within these fascicles were retracted and appeared congested with cytoskeletal and membranous components. Treatment with the antibody to the neural cell adhesion molecule defasciculated the thick outgrowths and permitted further axonal elongation.

Intimacy of the neuroeffector junction and resistance to alpha-adrenoceptor-blockade of the neurogenic contractile response in vasa deferentia from guinea pig and rat

The effect of phentolamine on the neurogenic contractile response in vasa deferentia from rat and guinea pig was studied during Wallerian degeneration. This response was also investigated after partial denervation (surgery or chemical sympathectomy by guanethidine treatment) in vasa deferentia from guinea pig. During Wallerian degeneration the response showed a gradual increase in sensitivity to phentolamine and was abolished in the late stages. The neurogenic contractile response of the partially denervated vas deferens was blocked by low concentrations of phentolamine. It is concluded that decreased intimacy of the neuroeffector junctions leads to increased susceptibility to alpha-adrenoceptor blockade of the contractile response to nerve stimulation. It is further concluded that the motor transmission in the vas deferens is essentially adrenergic. The resistance to alpha-adrenoceptor blockade of the initial phase of the contractile response to nerve stimulation of intact vasa deferentia from guinea pig and rat might well be explained by the "proximity theory" of Dale & Gaddum although participation of supplementary mediators cannot be excluded.

Chronic guanethidine and adrenal medullary function in the rat

The clinical application of intravenous angiography to study the cervicocerebrovascular system using the digital video subtraction system described in a companion article is reported. About 0.75 ml/kg of a standard 76% iodine contrast solution is injected into an antecubital vein using a power injector. Then 15-20 exposures of the head and neck region at a 1/sec rate are made on the image intensifier. The images are recorded by a high performance video system and the output signal is digitized for subsequent computer manipulation. The subtraction images of these vessels produced by the computer show the vessels clearly, even though they contain very low concentrations of contrast media. Standard exposure factors of 75–80 kVp, 9–10 msec at 800–1,000 mA are used. Clinically pertinent features of the data alteration and flow through the system and the step-by-step computer procedures used to achieve and analyze the various forms of subtracted images are described.

Five experimental and clinical cases demonstrate appropriate applications to cervicocerebrovascular disease: (1) evaluating the effects of surgical and medical therapy on atherosclerosis; (2) providing a screening angiographic test for patients with asymptomatic bruits and/or positive noninvasive studies; (3) evaluating patients who have significant generalized vascular disease either precluding or presenting hazardous contraindications to transarterial catheterization; (4) evaluating significantly aged patients in whom standard angiography has higher risk; and (5) evaluating currently asymptomatic patients who are medically at higher risk for developing atherosclerotic lesions. Numerous examples of the various types of image manipulations are presented: (1) linear subtraction; (2) logarithmic subtraction; (3) alterations of electronic contrast enhancement (map slope); (4) the usefulness of a series of angiographic images; and (5) the importance of multiple projections with this technique.

Persistence of an amine uptake system in cultured rat sympathetic neurons which use acetylcholine as their transmitter

Cultures of dissociated rat superior cervical ganglion neurons (SCGN) were treated with the sympatholytic agent, guanethidine. When treated within the first couple of weeks in vitro, the neurons were rapidly destroyed. The cells grew less susceptible to the toxic effects of guanethidine with age in vitro. Moreover, the apparent affinity, Km, of the transport molecule for norepinephrine (NE) and guanethidine remained essentially unchanged between 2 and 7 wk in culture, as did the maximum velocity of transport (Vmax). This is at a time when previous studies have shown these neurons to be using acetylcholine (ACh) as their neurotransmitter. Cultures which were grown without supporting cells and from which cholinergic synaptic interactions were recorded physiologically were processed for autoradiography after incubation with [3H]NE. All cell bodies and processes seen had silver grains accumulated over them. These experiments show that sympathetic neurons in vitro maintain their amine uptake system relatively unchanged, even though they use ACh as their transmitter. The implications of these findings are discussed.

Selectivity of neuronal degeneration produced by chronic guanethidine treatment

Chronic guanethidine treatment of rats produced extensive damage to sympathetic neurons of the superior cervical ganglion and pelvic plexus. No ultrastuctural changes were observed in parasympathetic cholinergic neurons in the ciliary ganglion and pelvic plexus, nor in sensory neurons in nodose and dorsal root ganglia. A total of only six nerve cell bodies free of degenerative changes were observed in sections of superior cervical ganglia from 20 rats. This suggests either that the earlier estimates of 5% cholinergic neurons in the superior cervical ganglion based on acetylcholinesterase staining are too high, or implies that sympathetic cholinergic neurons, unlike parasympathetic neurons, are damaged by chronic guanethidine treatment.

A study of long-term effects of guanethidine on peripheral noradrenergic neurones of the rat

In long-term experiments in rats the effects of guanethidine sulphate on peripheral adrenergic neurons in the heart, the vas deferens, the superior cervical ganglion and the ganglion innervating the vas deferens were studied in relation to the dosage and route of administration of the drug by biochemical, histofluorimetric and electron-microscopic methods. When administered daily in very high doses, i.e. 180 mg/kg orally or 25 mg/kg intraperitoneally, for several weeks guanethidine was found to induce toxic effects which appeared to be a result of mitochondrial changes in the ganglion cells. These changes were not directly related to the decrease in catecholamine content and the capacity of the neurones to retain exogeneous transmitter. The short neurones innervating the vas deferens appeared to be the structures most sensitive to guanethidine. As in the other tissues, however, the changes in these structures proved reversible to a considerable extent upon cessation of high-dose treatment. The structural changes induced in the animal by toxic doses of guanethidine are considered to have no bearing upon the pharmacological action of the drug under practical conditions.

Effects of chronic intracranial injection of low and high concentrations of guanethidine in the rat

Low (64 mug in 2 mul) or high 320-1280 mug in 2 mul) doses of guanethidine sulphate were injected daily for up to 19 days into the lateral hypothalamus, substantia nigra, locus coeruleus, dorsal raphe nucleus, or amygdala region of the rat brain. Effects on monoamine-containing neurons were determined using fluorescence histochemistry. The noradrenergic terminals of the hypothalamus were depleted over a diameter of 7 mm by both low and high doses of guanethidine whereas, even with high doses, the dopaminergic terminals of the median eminence, amygdala and acudate nucleus were only partially depleted. Fluorescence levels of dopaminergic cell bodies of the sub stantis nigra and 5HT-containing cell bodies of the dorsal raphe nucleus were unaltered by low doses of guanethidine. Low doses of guanethidine did not affect the fluorescence of the noradrenergic cell bodies of the locus coeruleus, however high doses caused a substantial reduction in fluorescence levels. Normal levels of fluorescence were observed in all catecholamine-containing neurons within 14 days from cessation of injections. Thus, the xon retraction and eventual degeneration of peripheral sympathetic adrenergic neurons, which occurs as a result of chronic intraperitoneal injections of guanethidine does not occur with the catecholamine-containing neurons in the central nervous system. The rapid recovery of centrat catecholamine-containing neurons is remarkable in view of the extensive areas of brain damage produced by chronic injection of such high concentrations of drug. Fluorescence in peripheral adrenergic nerves was unaffected by chronic injection of guanethidine into the lateral hypothalamus but adhesions of some internal organs were observed. Blood vessels in the vicinity of the cannula were heavily reinnervated by fluorescent fibres probably arising from intracranial catecholamine-containing neurons. Some of the advantages of intracranial injection of guanethidine compared to 6-hydroxydopamine for behavioral experiments are discussed.